rehabilitation of patients with borderline ovarian tumors

DOI: https://doi.org/10.29296/25877305-2018-08-06
Download full text PDF
Issue: 
8
Year: 
2018

Professor A. Solopova, MD; A. Vlasina; I. Rozanov, V. Moskvicheva I.M. Sechenov First Moscow State Medical University (Sechenov University)

The paper deals with the epidemiology, risk factors, and pathogenesis of borderline ovarian tumors. It describes medical rehabilitation methods in patients with this group of diseases.

Keywords: 
gynecology
borderline ovarian tumors
rehabilitation



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Silverberg S. Borderline ovarian tumors: consensus, controversy, and continuing challenges // Pathol. Case Rev. – 2006; 11: 9–17.
  2. Davydova I.Ju., Kuznetsov V.V., Karseladze A.I. i dr. Pogranichnye opuholi jaichnikov: sovremennyj vzgljad na problemu // Opuholi zhenskoj reproduktivnoj sistemy. – 2014; 2: 53–5.
  3. Hacker K., Uppal S., Johnston C. Principles of Treatment for Borderline, MicropapillarySerous, and Low-Grade Ovarian Cancer // J. Natl. Compr. Canc. Netw. – 2016; 14 (9): 1175–82.
  4. Gershenson D. Clinical management potential tumours of low malignancy // Best Pract. Res. Clin. Obstet. Gynaecol. – 2002; 16: 513–27.
  5. Ushijima K., Kawano K., Tsuda N. et al. Epithelial borderline ovarian tumor: Diagnosis and treatment strategy // Obstet. Gynecol. Sci. – 2015; 58 (3): 183–7.
  6. Scully R. International histological classification oftumors: histological typing of ovarian tumors / Geneva: WHO, 1999.
  7. Solopova A.G., Makatsarija A.D., Solopova A.E. i dr. Sklerokistoznye jaichniki: sovremennyj vzgljad na problemu // Akusherstvo, ginekologija i reproduktsija. – 2017; 11 (2): 57–68.
  8. Bagade P., Edmondson R., Nayar A. Management of borderline ovarian tumours // Obstet. Gynaecol. – 2012; 14 (2): 115–20.
  9. du Bois A., Trillsch F., Mahner S. et al. Management of borderline ovarian tumor // Ann. Oncol. – 2016; 27 (1): 20–2.
  10. Koensgen D., Weiss M., Assmann K. et al. Characterization and Management of Borderline Ovarian Tumors - Results of a Retrospective, Single-center Study of Patients Treated at the Department of Gynecology and Obstetrics of the University Medicine Greifswald // Anticancer Res. – 2018; 38 (3): 1539–45.
  11. Bonome T., Lee J., Park D. et al. Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary // Cancer Res. – 2005; 65 (22): 10602–12.
  12. Kopnin B.P., Kopnin P.B., Hromova N.V. i dr. Mnogolikij r53: raznoobrazie form, funktsij, opuhol'supressirujuschih i onkogennyh aktivnostej // Klin. onkogematologija. – 2008; 1: 2–9.
  13. Oliva E., Sarrió D., Brachtel E. et al. High frequency of beta-catenin mutations in borderline endometrioidtumours of the ovary // J. Pathol. – 2006; 208 (5): 708–13.
  14. Sieben N., Oosting J., Flanagan A. et al. Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors // J. Clin. Oncol. – 2005; 23: 7257–64.
  15. Davydova I.Ju., Kuznetsov V.V., Karseladze A.I. i dr. Seroznye pogranichnye opuholi jaichnikov: sovremennaja klassifikatsija i biologija // Ros. onkol. zhurn. – 2016; 21 (5): 228–32.
  16. Seong S., Kim D., Kim M. et al. Controversies in borderline ovarian tumors // J. Gynecol. Oncol. – 2015; 26 (4): 343–9.
  17. Davydova I.Ju., Kuznetsov V.V., Karseladze A.I. i dr. Pogranichnye opuholi jaichnikov: voprosy himioterapii i prognoza // Opuholi zhenskoj reproduktivnoj sistemy. – 2015; 3: 72–5.
  18. Mimura R., Kato F., Tha K. et al. Comparison between borderline ovarian tumors and carcinomas using semi-automated histogram analysis of diffusion-weighted imaging: focusing on solid components // Jpn. J. Radiol. – 2016; 34 (3): 229–37.
  19. Albu D., Albu C., Văduva C. et al. Diagnosis problems in a case of ovarian tumor – case presentation // Rom J. Morphol. Embryol. – 2016; 57 (4): 1437–42.
  20. Nechaev V., Magomedova Z. The Medical Rehabilitation: History and Definitions // Probl. Sotsialnoi Gig. Zdravookhranenniia i Istor. Med. – 2017; 25 (4): 221–5.
  21. Salakari M., Surakka T., Nurminen R. et al. Effects of rehabilitation among patients with advances cancer: a systematic review // Acta Oncol. – 2015; 54: 618.
  22. Karitskij A.P., Chulkova V.A., Pesterova E.V. i dr. Reabilitatsija onkologicheskogo bol'nogo kak osnova povyshenija kachestva ego zhizni // Vopr. onkologii. – 2015; 51 (2): 180–4.
  23. Solopova A.G., Tabakman Ju.Ju., Vorob'ev A.V. i dr. Perspektivy i realii reabilitatsii onkologicheskih bol'nyh // Akusherstvo, ginekologija i reproduktsija. – 2015; 9 (2): 80–8.
  24. Idrisova L.E., Solopova A.G., Tabakman Ju.Ju. i dr. Osnovnye napravlenija psihologicheskoj reabilitatsii onkoginekologicheskih bol'nyh // Akusherstvo, ginekologija i reproduktsija. – 2016; 4: 94–105.
  25. Bykov A.T., Shaposhnikov A.V., Maljarenko T.N. i dr. Effektivnost' bezlekarstvennyh metodov v profilaktike raka, lechenii i reabilitatsii onkologicheskih bol'nyh // Med. vestn. Juga Rossii. – 2014; 1: 5–14.
  26. Hodis H., Mack W., Henderson V. et al. Vascular effects of early vs late postmenopausal treatment with estradiol // N. Engl. J. Med. – 2016; 374: 1221–31.
  27. Sullivan S., Sarrel P., Nelson L. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause // Fertil. Steril. – 2016; 106 (7): 1588–99.
  28. Solopova A.G., Idrisova L.I., Chukanova E.M. Kontent-analiz: voprosy reabilitatsii patsientok reproduktivnogo vozrasta s postkastratsionnym sindromom // Vrach. – 2017; 5: 11–3.
  29. Trillsch F., Mahner S., Ruetzel J. et al. Clinical management of borderline ovarian tumors // Expert Rev. Anticancer Ther. – 2010; 10 (7): 1115–24.